Shares of Evotec SE (OTCMKTS:EVTCY – Get Free Report) passed above its fifty day moving average during trading on Friday. The stock has a fifty day moving average of $1.62 and traded as high as $1.82. Evotec shares last traded at $1.7750, with a volume of 273,775 shares trading hands.
Evotec Trading Down 4.8%
The firm has a fifty day moving average of $1.62 and a 200 day moving average of $2.49. The firm has a market capitalization of $558.07 million, a PE ratio of 4.12 and a beta of 0.98. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.50 and a current ratio of 2.57.
Evotec Company Profile
Evotec SE is a Germany-based biotechnology company that provides drug discovery and development services to pharmaceutical and biotechnology companies. The company combines scientific expertise, technology platforms and specialized laboratories to support the identification, optimization and development of potential medicines.
Its services cover a range of activities, including target discovery, screening, medicinal chemistry, translational research, preclinical development and selected clinical development programs.
Featured Stories
- Five stocks we like better than Evotec
- After the Midterms, Which of These 3 Defense ETFs Looks Strongest?
- The Ugly Truth Behind SoundHound’s Q3 Results
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
